Abstract
An association of a loss of DNA replication control and the activation of erbB oncogenes can be deduced from studies with different cancers (1-5). In the first study on ovarian cancer 26% of the tumors had c-erbB-2 amplifications (6). The correlation between c-erbB-2 amplification and expression on mRNA and protein level was perfect. The median survival time of patients with ovarian cancers was negatively correlated to the degree of amplification. The association of egfr (c-erbB-1) amplification and overexpression with ovarian cancer prognosis has not been investigated as extensively as for c-erbB-2. EGF-R is expressed in normal ovarian epithelium and patients whose ovarian cancer continues to express EGF-R have a worse prognosis (7). Rearrangements of the egfr gene in ovarian cancer were also described, as identified by Southern blot analysis (8). Bauknecht submitted that a failure of chemotherapy was seen for ovarian cancers with low EGF-R expression (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., et al. (1995) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcino-mas and malignant gliomas. Cancer Res. 55, 3140–3148.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., et al. (1995) Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55, 5536–5539.
Lin, J. T., Wu, M. S., Shun, C. T., Lee, W. J., Sheu, J. C., and Wang, T. H. (1995) Occurrence of micro satellite instability in gastric carcinoma is associated with enhanced expression of c-erbB-2 oncoprotein. Cancer Res. 55, 1428–1430.
Brandt, B., Vogt, U., Schlotter, C. M., Jackisch, C., Werkmeister, R., Thomas, M., et al. (1995) Prognostic relevance of aberrations of the erbB oncogenes in breast, ovarian, oral and lung cancer: double-differential PCR for clinical diagnosis. Gene 159, 35–42.
Brandt, B., Beckmann, A., Gebhardt, F., Rötger, A., Jackisch, C., Assmann, G., and Zänker, K. S. (1997) Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment. Cancer Lett. 118, 143–151.
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712.
Bast, R. C., Boyer, C. M., Jacobs, I., Xu, F. J., Wu, S., Wiener, J., et al. (1993) Cell growth regulation in epithelial ovarian cancer. Cancer 71, 597–601.
Bauknecht, T., Angel, P., Kohler, M., Kommoss, F., Birmelin, G., Pfleiderer, A., and Wagner, E. (1993) Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Cancer 71, 419–429.
Brandt, B., Vogt, U., Harms, F., Bosse, U., Zänker, K. S., Assmann, G. (1995) Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissue, and comparison to cellular DNA content. Gene 159, 29–34.
Rötger, A., Brandt, B., and Barnekow, A. (1997) Competitive-differential PCR for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes. DNA Cell Biol. 16, 443–448.
(1989) Molecular Cloning, 2nded. (Sambrock, J., Fritsch, E. F., and Maniatis, T., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 1.25–1.31.
(1990) PCR Protocols: A guide to methods and applications (Inis, M. A., Gelfand, D. H., Sninsky, J. I., and White, T. J., eds.), Academic, New York.
Celi, F. S., Zenilman, M. E., Shuldiner, A. R. (1993). A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res. 21, 1047.
Warburg, O. and Christian, W. (1941) Biochem. Z. 310, 384.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Brandt, B., Beckmann, A., Roetger, A., Gebhardt, F. (2000). Double- and Competitive-Differential PCR for Gene Dosage Quantitation. In: Bartlett, J.M.S. (eds) Ovarian Cancer. Methods in Molecular Medicine™, vol 39. Humana Press. https://doi.org/10.1385/1-59259-071-3:347
Download citation
DOI: https://doi.org/10.1385/1-59259-071-3:347
Publisher Name: Humana Press
Print ISBN: 978-0-89603-583-6
Online ISBN: 978-1-59259-071-1
eBook Packages: Springer Protocols